Comparative evaluation of possible ocular photochemical toxicity of fluoroquinolones meant for ocular use in experimental models

Indian Journal of Experimental Biology

Volumn 44, Issue 5, 2006, Pages 387-391

  Velpandian, T ^a   Bankoti, R ^a   Humayun, S ^a   Ravi, A K ^a   Kumari, S S ^a   Biswas, N R ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bovine vitreous; Eye; Fluoroquinolones; HET CAM UV model; Phototoxicity

Indexed keywords

QUINOLONE DERIVATIVE;

ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; EYE; PHOTOCHEMISTRY; ULTRAVIOLET SPECTROPHOTOMETRY;

EYE; FLUOROQUINOLONES; MODELS, ANIMAL; PHOTOCHEMISTRY; SPECTROPHOTOMETRY, ULTRAVIOLET;

BACTERIA (MICROORGANISMS); BOVINAE;

EID: 33646573022     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Roberts J E, Screening for ocular phototoxicity, Int J Toxicol, 21 (2002) 491.
2. Rosentiel N V & Adam D, Quinolone antibacterials. An update of their pharmacology and therapeutic use, Drugs, 47 (1994) 872.
3. Neumann J, Holzle E, Lehmann P, Rosenbruch M, Klaucic A & Plewig G, Photohen's egg test: A model for phototoxicity, Br J Derm, 136 (1997) 326.
4. Abel R & Boyle G L, Dissecting intraocular tissue for intraocular drug studies, Invest Ophthalmol Vis Sci, 15 (1976) 216.
5. Matsumoto M, Kojima K, Nagano H, Matsubara S & Yokota T, Photostability and biological activity of fluoroquinolones at the 8 position after UV irradiation, Antimicrobial Agents Chemother, 36 (1992) 1715.
6. Robertson D G, Epling G A, Kiely J S, Bailey D L & Song B, Mechanistic studies on the phototoxic potential of PD 117596, a quinolone antibacterial compound, Toxicol Appl Pharm, 111 (1991) 221.
7. Umezawa N, Arakane K, Ryu A, Mashiko S, Hirobe M & Nagano T, Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents, Arch Biochem Biophys, 342 (1997) 275.
8. Foote C S, Photosensitized oxidation and singlet oxygen: Consequences in biological systems, in Free radicals in biology, (Academic Press, New York) 1976, 85.
9. Stahlman R & Lode H, Toxicity of quinolones, Drugs, 58 (1999) 37.
10. Domagala J M, Structure activity relationship for the quinolone antibacterials, J Antimicrob Chemother, 33 (1994) 685.
11. Rubinstein E, History of quinolone and their side-effects. Chemotherapy, 47 (2001) 3.
12. Lipsky B A & Baker C A, FQ toxicity profiles: A review focusing on newer agents, Clin Inf Dis, 28 (1999) 352.
13. Oliphant C M, Quinolones: A comprehensive review, Am Fam Phys, 65 (2002) 455.
14. Fish D N, FQ adverse effects and drug interaction, Pharmacotherapy, 10 (2001) 253S.
15. Christ W, Lehnert T & Ulbrich B, Specific toxicologic aspects of the quinolones, Rev Infect Dis, 10 (1988) S141.
16. Krasula R W & Pernet A G, Comparison of organ specific toxicity of temafloxacin in animal and humans, Am J Med, 91 (1991) 38.
17. Corrado M L, Struble W E, Peter C, Hoagland V & Sabbaj J, Norfloxacin: Review of safety studies, Am J Med, 82 (1987) 22.
18. Shimoda K, Mechanisms of quinolones phototoxicity, Toxicol Lett, 102-103 (1998) 369.
19. Traynor N J, Barratt M D, Lovell W W, Ferguson J & Gibbs N K, Comparison of an in vitro cellular phototoxicity model against controlled clinical trials of fluoroquinolone skin phototoxicity, Toxicol in vitro, 14 (2000) 275.
20. Gupta S K, Joshi S & Zhingan S, Topical norfloxacin a new drug for the treatment of Pseudomonas corneal ulcers- an experimental study, Med Sci Res, 17 (1989) 769.
21. Donnenfeld E D, Schrier A, Perry H D, Aulicino T, Gombert M E & Snyder R, Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor, Ophthalmology, 101 (1994) 902.
22. Velpandian T, Gupta S K, Gupta Y K, Aggarwal H C & Biswas N R, Comparative studies on topical lomefloxacin and ciprofloxacin on ocular kinetic and experimental corneal ulcer, J Ocul Pharmcol Ther, 15 (1999) 505.
23. Vyas U, Desai T & Shah C, Evaluation of sparfloxacin eye drop in the management of conjunctival and corneal infection, J Indian Med Assoc, 100 (2002) 398.
24. Tungsiripat T, Sarayba M A, Kaufman M B, Sweet P M, Taban M, Carpenter T R & McDonnell P J, Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model, Am J Ophthalmol, 136 (2003) 76.
25. Eaton J W, Is the lens canned? Free Radic Biol Med, 11 (1991) 207.
26. Varma S D, Kumar S & Richards R D, Light-induced damage to ocular lens cation pump: Prevention by vitamin C, Proc Natl Acad Sci U S A, 76 (1979) 3504.
27. Jeffrey A M, Shao L, Brendler-Schwaab S Y, Schluter G & Williams G M, Photochemical mutagenecity of phototoxic and photochemically carcinogenic fluoroquinolones in comparison with the photostable moxifloxacin, Arch Toxicol, 74 (2000) 555.
28. Ferguson J & Dawe R, Phototoxicity in quinolones: Comparison of ciprofloxacin and grepafloxacin, J Antimicro Chem, 40 (1997) 93.
29. Norrby S R & Lietman P S, Safety and tolerability of fluoroquinolones, Drugs, 45 (1993) 59.
30. Patterson D R, Quinolone toxicity: Methods of assessment, Am J Med. 91 (1991) 35S.
31. Lerman S, Photosensitizing drugs and their possible role in enhancing ocular toxicity, Ophthalmology, 93 (1986) 304.